Abortion bans fuel a rise in high-risk patients heading to Illinois hospitals

When she was around 22 weeks pregnant, the patient found out that the son she was carrying didn’t have kidneys and his lungs wouldn’t develop. If he survived the birth, he would struggle to breathe and die within hours.

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Denecimig?

Denecimig is a monoclonal antibody commercialized by Novo Nordisk, with a leading Phase III program in Hemophilia A (Factor VIII Deficiency).

March 14, 2024

MacroGenics stops further dosing in Phase 2 prostate cancer drug trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 1, 2024

Pandemic-related immunity gap in kids explains surge of respiratory infections in children in China, says WHO

Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among

November 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.